Inside the Smithsonian’s “Racial Brain Collection” and the Eugenics Project Behind It
By Amy Goodman,
Democracy Now!
| 08. 18. 2023
The Smithsonian has formed a task force to address the massive collection of human remains held by its museums, which includes 255 human brains that were removed primarily from dead Black and Indigenous people, as well as other people of color, without the consent or knowledge of their families. The so-called racial brain collection was revealed by a Washington Post investigation. It was mostly collected in the first half of the 20th century at the behest of Ales Hrdlicka, a racist anthropologist who was trying to scientifically prove the superiority of white people. We speak with reporters Nicole Dungca and Claire Healy about the series and what they found. Dungca is also president of the Asian American Journalists Association.
Transcript
This is a rush transcript. Copy may not be in its final form.
AMY GOODMAN: We end today’s looking at a major investigation by The Washington Post that revealed the Smithsonian Institution holds a so-called racial brain collection that contains 255 brains gathered in the first half of the 20th century. Much of it was collected at the behest of a...
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...